|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 | |||
| C07H 21/04 |
| (11) | Number of the document | 3212230 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15854895.8 |
| Date of filing the European patent application | 2015-10-29 | |
| (97) | Date of publication of the European application | 2017-09-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/058108 |
| Date | 2015-10-29 |
| (87) | Number | WO 2016/069919 |
| Date | 2016-05-06 |
| (30) | Number | Date | Country code |
| 201462072031 P | 2014-10-29 | US | |
| 201562134955 P | 2015-03-18 | US |
| (72) |
GARDAI, Shyra, US
LAW, Che-Leung, US
PENG, Stanford, US
YANG, Jing, US
NEFF-LAFORD, Haley, US
|
| (73) |
Seagen Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES |
| DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES |